Robeco Capital Growth Funds (“the Funds”) are distinguished by their respective specific investment policies or any other specific features. Please read carefully for the risks of the Funds:
Investors may suffer substantial losses of their investments in the Funds. Investor should not invest in the Funds solely based on the information provided in this document and should read the offering documents (including potential risks involved) for details. Investment involves risks. Past performance is not indicative of future performance. The information contained in this website is provided for reference only and does not constitute any investment advice. Investors are advised to seek independent advice before making any investment decision. Please refer to the relevant offering documents for details including the risk factors before making any investment decisions. This web page is published by Robeco Hong Kong Limited and has not been reviewed by the Securities and Futures Commission. You must read the above information before proceeding. By clicking the “I AGREE” button below, you acknowledge that you have read the relevant risk disclosure statements.
We believe the market often underestimates the impact of long term value creation through the high cash returns on invested capital that result from sound business models and solid management. Our investment philosophy is rooted in our strong belief that these market inefficiencies can be exploited through an inspired, responsible and disciplined investment process.
Stock selection is the core of the process of this strategy. The quality, depth and focus of our research are the keys to accurately and consistently identifying the factors that will drive a company’s valuation. Over time, high returns on invested capital, strong free cash flow and a good ESG performance will deliver superior returns for investors. A long-term investment horizon is crucial if investors are to benefit from this potential to create value. Our motto is ‘Make your case, be skeptical and remain patient’.
This strategy is managed by the Global Equity team, which consists of a stable and experienced portfolio management team and research analysts with individual sector specializations.